RGT 7.94% 29.0¢ argent biopharma limited

Ann: Trading Halt, page-197

  1. 1,049 Posts.
    lightbulb Created with Sketch. 241
    Ok... let's look at these

    (1) This ann is nothing really new. We already know the GMP is coming
    (2) The expected revenue generate from EpiCann in the first year is only 1 million, which is lower than a lot of expectation
    (3) Risk of capital raising
    (4) 1 million deposit still missing from VC
    (5) A lot of holders just get impatient with the recent stagnation of SP and decide to leave

    Prediction: SP may go back to 11c or even 10.5c before closing

    But don't get me wrong, I do believe MXC has a lot of potential though

    just my opinion

    DYOR
    Last edited by Sparkz918: 25/01/18
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.